Nefecon and Ambrisentan in IgA Nephropathy
NCT07030894
·
clinicaltrials.gov ↗
PHASE4
Phase
RECRUITING
Status
129
Enrollment
OTHER
Sponsor class
Conditions
IgA Nephropathy
Chronic Kidney Disease
Proteinuria
Interventions
DRUG:
"Nefecon®","Ambrisentan"
Sponsor
The First Hospital of Jilin University